Pueraria Mirifica (Kwao Krua): Evidence, Safety and Sourcing

Are you looking for a natural way to improve your health and wellbeing? Pueraria mirifica extract is becoming popular as a helpful remedy for many health issues. Used for centuries in traditional Asia...

Pueraria mirifica, known in Thailand as kwao krua or white kwao krua, is a tuberous root with strong oestrogen-like activity. It is sold in women’s health and “beauty” supplements across Southeast Asia. It is also one of the few botanicals that a major regulator has singled out for special control. This guide covers what it is, what the human evidence shows, the safety and regulatory picture, and how to specify it.

What Is Pueraria Mirifica?

Pueraria mirifica is native to Thailand and Myanmar and belongs to the same genus as kudzu. Its botanical name in the scientific literature is Pueraria candollei var. mirifica. The tuberous root has a long history of use in upland Thailand as a rejuvenating remedy after menopause [1].

The root contains phytoestrogens, plant compounds that act on the body’s oestrogen receptors. Its distinctive compounds are miroestrol and deoxymiroestrol, which are strongly oestrogenic, alongside isoflavones such as daidzein and genistein. This activity is the reason for both its popularity and its regulation.

Not the Same as Kudzu or Red Kwao Krua

Three different plants are sold under similar names, and they are not interchangeable:

Because the names overlap, buyers should ask for identity testing that separates these three plants.

What the Research Says

The human evidence is limited and of low quality. The only systematic review we found calls the benefits inconclusive.

  • Menopausal symptoms. A 2018 systematic review included 8 studies with 309 menopausal women. In five studies, symptom scores fell by about 50% from baseline, but the authors judged efficacy inconclusive [1].
  • Quality problems. The trials had design and reporting flaws, a high risk of bias and low quality scores. The studies did not define the active ingredients or the source of the plant material. Serum C-reactive protein, an inflammation marker, doubled [1].
  • One oral trial in detail. In a 24-week trial, 51 postmenopausal women took 20, 30 or 50 mg a day and 20 took placebo. A bone-turnover marker fell compared with placebo. The lining of the womb did not thicken, but the placebo group was small [2].

These summaries describe published research on the ingredient. They are not claims for any finished product; claims on finished products must meet the rules of the market where they are sold.

The review’s authors call for better-defined material, long-term safety data and stronger pharmacovigilance before efficacy can be judged [1]. The trials did not test claims such as breast enlargement or firmer skin, and relief of hot flushes remains unproven [1].

Safety and Regulation

Japan’s “designated ingredient” rule. Between 2012 and 2017, Japan received many reports of irregular vaginal bleeding and menstrual disorders linked to health foods containing Pueraria mirifica. Many of these products claimed breast-enhancing or body-shaping effects [3].

Japan then amended its Food Sanitation Act. From 1 June 2020, Pueraria mirifica became one of four “designated ingredients” in health foods, alongside Coleus forskohlii, greater celandine and black cohosh [4]. Products must carry a special label, and businesses must report every health complaint to the local health centre [4].

Japan’s official guidance lists the reported harms as irregular periods and bleeding, abdominal pain, vomiting, diarrhoea, rashes and hives [4]. In a Japanese survey, almost half of the people who had used P. mirifica foods reported an adverse event. These were self-reports, not controlled data [3].

In clinical trials. Adverse events such as breast tenderness, vaginal spotting and dizziness were reported at similar rates with Pueraria mirifica, conjugated oestrogens and placebo [1]. The trials were small and short, so they cannot rule out rarer or longer-term effects.

Who should avoid it. Because it acts like oestrogen, products should carry warnings for pregnancy, breast-feeding and oestrogen-sensitive conditions. People taking hormonal medicines should speak to a doctor first.

Malaysia. Rules for oestrogenic botanicals differ between markets and product categories. Confirm the status of your product with NPRA before formulating. Our FC | Comply team can advise on the documents you need.

Standardisation: What the Numbers Mean

Most extracts are sold on a total-flavonoid figure measured by UV. This is a broad colour-reaction assay. It does not identify single compounds, and it does not measure miroestrol or deoxymiroestrol, which drive most of the oestrogenic activity.

Content also varies with plant origin and harvest. The systematic review found that trial materials were not standardised, which is one reason results cannot be compared [1]. For consistency, ask for an HPLC profile of the isoflavones and, where available, of miroestrol and deoxymiroestrol.

What to Check Before You Buy

  • Botanical name and plant part. Pueraria mirifica (P. candollei var. mirifica) tuberous root.
  • Identity. A test that separates it from P. lobata and Butea superba, such as an HPLC fingerprint or DNA test.
  • Marker content. Total flavonoids with the method, plus an HPLC isoflavone profile.
  • Miroestrol and deoxymiroestrol. Where the supplier can measure them.
  • Extraction details. Solvent, and any carrier with its percentage.
  • Contaminants. Loss on drying, heavy metals, pesticide residues and microbiology.
  • Documents. Halal certificate, batch number, manufacture and retest dates.

Formulators working on women’s health products also consider other botanicals, such as wild yam. Each needs its own evidence and regulatory check.

Frequently Asked Questions

What is kwao krua?
Kwao krua is the Thai name for several roots. White kwao krua (kwao krua khao) is Pueraria mirifica. Red kwao krua is Butea superba, a different plant.

Is Pueraria mirifica the same as kudzu?
No. Kudzu is Pueraria lobata, a related species with different main compounds. The two should not be substituted for each other.

Does Pueraria mirifica work for menopause?
The evidence is inconclusive. A systematic review of 8 small studies found high risk of bias and undefined plant material [1].

Why is Pueraria mirifica restricted in Japan?
After many reports of irregular bleeding and menstrual problems, Japan made it a “designated ingredient” in 2020. Products now need special labels and complaint reporting [3][4].

What grade does FC Materials supply?
Our Pueraria Mirifica Extract is standardised to more than 40% flavonoids (UV) and is Halal-certified. Ask us for the specification, certificate of analysis and identity data.

References

  1. Kongkaew C, Scholfield NC, Dhippayom T, et al. Efficacy and safety of Pueraria candollei var. mirifica (Airy Shaw & Suvat.) Niyomdham for menopausal women: a systematic review of clinical trials and the way forward. J Ethnopharmacol. 2018;216:162-74. doi:10.1016/j.jep.2018.01.028
  2. Manonai J, Chittacharoen A, Udomsubpayakul U, et al. Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women. Menopause. 2008;15(3):530-5. doi:10.1097/gme.0b013e31815c5fd8
  3. Chiba T, Tanemura N, Nishijima C, et al. Recognition and prevalence of “designated ingredient, etc.” in health foods [in Japanese]. Shokuhin Eiseigaku Zasshi. 2022;63(1):20-6. doi:10.3358/shokueishi.63.20
  4. National Institutes of Biomedical Innovation, Health and Nutrition (Japan). About designated ingredients, etc. [in Japanese]. HFNet; updated 1 June 2020. hfnet.nibn.go.jp.

Sourcing Pueraria mirifica for your formulation?

FC Materials supplies Pueraria mirifica (white kwao krua) extract to supplement and cosmetic manufacturers. Tell us your product needs and our team will respond with specs, pricing and MOQ.

Request a Quote →

Share your love

Leave a Reply

Your email address will not be published. Required fields are marked *